Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.02 USD | +2.82% | -3.14% | +128.52% |
Apr. 29 | Stoke Therapeutics Appoints Thomas Leggett CFO | MT |
Apr. 29 | Stoke Therapeutics, Inc. Announces Executive Changes, Effective May 7, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+128.52% | 626M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Stoke Therapeutics : Needham Adjusts Stoke Therapeutics' Price Target to $56 From $48, Keeps at Buy